ClinicalTrials.gg
RecruitingNCT07351799Updated Jan 20, 2026

Mindfulness and Meditation Based Lactation Education on Maternal Breastmilk in the Neonatal ICU

An interventional study of Standard of Care and Mindfulness-based Intervention in Lactation, Mindfulness and NICU, sponsored by Mayo Clinic. Recruiting at 1 site in United States. Open to female participants aged 20 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-01-20.

Primary conditionBreast Milk ExpressionRegistry: Breast FeedingReclassifiedWhy we changed it
Registry
Breast Feeding — the first condition term the registry derived for this study.
ClinicalTrials.gg
Breast Milk Expression
Why
  1. The study's listed conditions name Breast Milk Expression, a narrower term within Breast Feeding.
Confidence
High: the new condition is named in the study's own listed conditions. Of 351 hand-checked studies reclassified this way, 68% were exactly right and 84% in the right disease family; the registry's first term was right for 5% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by Mayo Clinic · Not applicable, Interventional, and Other

From the registry’s dates

  • Registered 3 months after the study started (first participant enrolled Sep 2025, registered Jan 2026).
  • Started Sep 2025; still recruiting 1 year 1 month later.
Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
20 Years and older
Sex
Female
01

Study summary

The purpose of this research is to investigate associations between mindfulness and meditation techniques and changes in maternal breastmilk in the mother pumping for her NICU infant.

02

Conditions studied

  • Lactation
  • Mindfulness
  • NICU
  • Breastmilk
  • Neonatal
  • Meditation
  • Pumping, Breast
  • Cortisol
  • Oxytocin
  • Anxiety
  • Depression

Browse trials for

Keywords

  • lactation
  • mindfulness
  • NICU
  • breastmilk
  • Neonatal
  • meditation
  • pumping, breast
  • cortisol
  • oxytocin
  • anxiety
  • Depression
03

In context

Breast Milk Expression Reclassified

88 studies on the registry are indexed under Breast Milk Expression; 20 are open to participants now.

This study's planned enrollment of 40 is below the median of 60 across 49 interventional studies indexed under Breast Milk Expression.

Browse Breast Milk Expression studies →

Lead sponsor

Mayo Clinic is the lead sponsor of 3,269 studies on the registry; 672 are open to participants now.

Of its 452 completed or terminated interventional studies of FDA-regulated products, 321 (71%) have results posted.

Compared within Breast Milk Expression, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Breast Feeding. The counts are of registry records indexed under each term, refreshed daily. How we classify →

04

Who can participate

Ages eligible
20 Years and older
Sexes eligible
Female
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Maternal age > 20 years of age
  • Read, write and understand English
  • Infant NICU admit
  • Infant birthplace of Rochester, MN (Mayo Clinic)
  • Maternal adherence to pumping ≥ 8 times in 24 hours
  • Mother enrolled within 72 hours of birth
  • Gestational age of neonate at birth of \< 34 0/7 weeks

Exclusion criteria

Exclusion Criteria:

  • Maternal extensive existing mindfulness practice
  • Maternal breast/chest surgery
  • Maternal polycystic ovarian syndrome (PCOS)
  • Maternal current illicit substance abuse
  • Diagnosis of maternal current severe mental health concerns
  • Maternal multiple gestation (twins or higher order) pregnancy and delivery
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
40 participants (estimated)

Study arms

  • Active comparator
    Standard of Care

    Mothers in the standard of care arm will undergo a standard lactation admission visit

    Behavioral: Standard of Care

  • Experimental
    Mindfulness-Based

    Mothers in the mindfulness-based arm will receive mindfulness-based lactation education along with a standard lactation admission visit

    Behavioral: Mindfulness-based Intervention

Interventions

  • BehavioralStandard of Care

    No additional session with the lactation consultant will be provided beyond the standard of care lactation admission visit with a lactation consultant within 72 hours of their infant's admission to the NICU. On days 0, 10 and 20, participants will be asked to record pumping session times and breastmilk volumes expressed for 24 hours, collect salivary oxytocin sample and salivary cortisol sample at minute 4 of one pumping session, and fill out the GAD7, PSS, and PHQ-8 surveys.

  • BehavioralMindfulness-based Intervention

    In addition to the standard of care lactation admission visit, participants will receive an additional session with the lactation consultant for mindfulness-based lactation education. Participants will also be provided with a pumping meditation audio recording that they will be asked to listen to at least once daily for the next 20 days. On days 0, 10 and 20, participants will be asked to record pumping session times and breastmilk volumes expressed for 24 hours, collect salivary oxytocin sample and salivary cortisol sample at minute 4 of one pumping session, and fill out the GAD7, PSS, and PHQ-8 surveys. In addition, the intervention group participants will also be asked to record the number of times they listened to the recording daily, minutes listened to recording daily, and time of day listened to recording.

06

What researchers measure

Primary outcomes

  1. Change in breastmilk volume

    Volume will be reported in milliliters (mL)

    Time frame: Baseline, 10 days, 20 days

Secondary outcomes

  1. Change in salivary oxytocin

    Time frame: Baseline, 10 days, 20 days

  2. Change in salivary cortisol

    Time frame: Baseline, 10 days, 20 days

07

Study locations

1 of 1 sites recruiting
  • Mayo Clinic in Rochester
    Rochester, Minnesota 55905, United States
    Recruiting
    • Ashley Thompson, BSN, RN, IBCLC · ContactNICULactationStu@mayo.edu · 507-422-5523
    • Tawney DeBoth, BSN, RN, IBCLC · ContactNICULactationStu@mayo.edu · 507-422-5523
    • Ashley Elizabeth Thompson, BSN, RN, IBCLC · Principal investigator
    • Tawney DeBoth, BSN, RN, IBCLC · Sub investigator
    • Senna Hesbyn, BSN, RN, IBCLC · Sub investigator
    • Melissa Kurke, BSN, RN, IBCLC · Sub investigator
    • Alecia Robin, BSN, RN, IBCLC · Sub investigator
08

References and documents

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 20, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07351799
Lead sponsor
Mayo Clinic
Responsible party
Ashley E. Thompson (Principal Investigator, Mayo Clinic) — Principal investigator
First posted
Jan 20, 2026
Start date
Sep 22, 2025
Primary completion
Nov 2, 2026 (estimated)
Completion
Nov 2, 2026 (estimated)
Last update
Jan 20, 2026

Study contacts

Ashley Thompson
principal investigator · Mayo Clinic

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion